Novavax (NVAX) Receivables - Net (2010 - 2026)
Novavax (NVAX) posted Receivables - Net of $18.74 million for Q2 2026, down 91.7% from $226.4 million a year earlier and down 19.6% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Receivables - Net (2010 - 2026) Analysis & Trends
At the end of FY2025, Novavax's Receivables - Net came in at $106.45 million, down 1.7% from FY2024.
- Annual Receivables - Net shows a five-year compound annual growth rate of -16.5% (FY2020 to FY2025).
- In prior years, Novavax's Receivables - Net was $108.29 million in FY2024 (-63.6%), $297.24 million in FY2023 (+260.8%), $82.38 million in FY2022 (-81.9%) and $454.99 million in FY2021 (+73.7%).
- The Q2 2026 figure stands as the lowest quarterly Receivables - Net since Q3 2020.
- On a year-over-year basis, Receivables - Net has declined in each of the last four quarters, with growth averaging 52.7% over the last eight quarters.
- The strongest year-over-year quarter for Receivables - Net in the past five years was Q1 2022, with growth of 740.4%; the weakest was Q2 2024, with a decline of 91.9%.
- According to Business Quant data, Receivables - Net for the three prior quarters was $23.31 million (Q1 2026), $106.45 million (Q4 2025) and $34.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Novavax | 1.80 Bn | -1.06 Bn | 44.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 49.16 Mn |
| Jun 30, 2026 | 18.74 Mn |
| Mar 31, 2026 | 23.31 Mn |
| Dec 31, 2025 | 106.45 Mn |
| Sep 30, 2025 | 34.17 Mn |
| Jun 30, 2025 | 226.40 Mn |
| Mar 31, 2025 | 44.51 Mn |
| Dec 31, 2024 | 108.29 Mn |
| Sep 30, 2024 | 94.96 Mn |
| Jun 30, 2024 | 32.11 Mn |
| Mar 31, 2024 | 21.38 Mn |
| Dec 31, 2023 | 297.24 Mn |
| Sep 30, 2023 | 123.66 Mn |
| Jun 30, 2023 | 394.89 Mn |
| Mar 31, 2023 | 112.85 Mn |
| Dec 31, 2022 | 82.38 Mn |
| Sep 30, 2022 | 111.65 Mn |
| Jun 30, 2022 | 194.53 Mn |
| Mar 31, 2022 | 478.16 Mn |
| Dec 31, 2021 | 454.99 Mn |
API Access
Novavax Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();